1. miR-203 Expression in Exfoliated Cells of Tongue Coating Represents a Sensitive and Specific Biomarker of Gastroesophageal Reflux Disease
    Xiuli Yan et al, 2016, Gastroenterology Research and Practice CrossRef
  2. New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies
    Erika Larrea et al, 2016, IJMS CrossRef
  3. Exosomes: Potential in Cancer Diagnosis and Therapy
    Phillip Munson et al, 2015, Medicines CrossRef
  4. The role of MicroRNA molecules and MicroRNA-regulating machinery in the pathogenesis and progression of epithelial ovarian cancer
    Xiyin Wang et al, 2017, Gynecologic Oncology CrossRef
  5. Beyond circulating microRNA biomarkers: Urinary microRNAs in ovarian and breast cancer
    Maria Luisa Gasparri et al, 2017, Tumour Biol. CrossRef
  6. A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies
    Lin Cheng et al, 2017, J Ovarian Res CrossRef
  7. Complex Determinants of Epithelial: Mesenchymal Phenotypic Plasticity in Ovarian Cancer.
    Yuliya Klymenko et al, 2017, Cancers (Basel) CrossRef
  8. Down-regulation of miR-30a-3p/5p promotes esophageal squamous cell carcinoma cell proliferation by activating the Wnt signaling pathway.
    Bo Qi et al, 2017, World J Gastroenterol CrossRef
  9. Characterization of exosomal RNAs derived from human gastric cancer cells by deep sequencing
    Jia Ren et al, 2017, Tumour Biol. CrossRef
  10. The miR-30 family: Versatile players in breast cancer
    Su-Jin Yang et al, 2017, Tumour Biol. CrossRef
  11. Identification and expression analysis of microRNAs in medaka gonads
    Weiwei Qiu et al, 2018, Gene CrossRef
  12. Identification of the key miRNAs associated with survival time in stomach adenocarcinoma
    Li Liang et al, 2017 CrossRef
  13. Exploring the RNA landscape of endothelial exosomes
    Jennifer Pérez-Boza et al, 2018, RNA CrossRef
  14. MicroRNA-30a Mediates Cell Migration and Invasion by Targeting Metadherin in Colorectal Cancer
    Huifang Jin et al, 2018, Technol Cancer Res Treat CrossRef
  15. MicroRNA-30a-5p inhibits gallbladder cancer cell proliferation, migration and metastasis by targeting E2F7
    Yuan-Yuan Ye et al, 2018, Cell Death Dis CrossRef
  16. The role of microRNAs and nanoparticles in ovarian cancer: a review
    Leila Kafshdooz et al, 2018, Artificial Cells, Nanomedicine, and Biotechnology CrossRef
  17. Ascites-Derived Extracellular microRNAs as Potential Biomarkers for Ovarian Cancer
    Luděk Záveský et al, 2018, Reprod Sci CrossRef
  18. Extracellular vesicles in cancer - implications for future improvements in cancer care.
    Rong Xu et al, 2018, Nat Rev Clin Oncol CrossRef
  19. miR-30 Family: A Promising Regulator in Development and Disease
    Ling Mao et al, 2018, BioMed Research International CrossRef
  20. microRNA-30d mediated breast cancer invasion, migration, and EMT by targeting KLF11 and activating STAT3 pathway.
    Mingli Han et al, 2018, J Cell Biochem CrossRef
  21. MiR-30a-5p inhibits osteosarcoma cell proliferation and migration by targeting FOXD1
    Jun Tao et al, 2018, Biochemical and Biophysical Research Communications CrossRef
  22. MiR-31 and miR-143 affect steroid hormone synthesis and inhibit cell apoptosis in bovine granulosa cells through FSHR
    Zhe Zhang et al, 2018, Theriogenology CrossRef
  23. Exosomes as Biomarker of Cancer
    Aleena Sumrin et al, 2018, Braz. arch. biol. technol. CrossRef
  24. Detecting ovarian cancer using extracellular vesicles: progress and possibilities
    Emanuela Carollo et al, 2019, Biochm. Soc. Trans. CrossRef
  25. Urine Biomarkers for the Early Detection of Ovarian Cancer – Are We There Yet?
    Kelly Grayson et al, 2019, Biomark�Cancer CrossRef
  26. null
    Hulya Yazici, 2019 CrossRef
  27. Comparison of plasma and urinary microRNA-483-5p for the diagnosis of adrenocortical malignancy.
    Abel Decmann et al, 2019, J Biotechnol CrossRef
  28. MicroRNA in Ovarian Cancer: Biology, Pathogenesis, and Therapeutic Opportunities.
    San-Nung Chen et al, 2019, Int J Environ Res Public Health CrossRef
  29. The potential role of exosomes derived from ovarian cancer cells for diagnostic and therapeutic approaches
    Changwon Yang et al, 2019, J Cell Physiol CrossRef
  30. null
    Ivan Igaz et al, 2015 CrossRef
  31. Liquid Biopsies for Ovarian Carcinoma: How Blood Tests May Improve the Clinical Management of a Deadly Disease
    null Mari et al, 2019, Cancers CrossRef
  32. null
    Gabriel D. Dakubo, 2019 CrossRef
  33. Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.
    Wen-Fang Li et al, 2016, Tumour Biol CrossRef
  34. CD109 is a component of exosome secreted from cultured cells
    Hiroki Sakakura et al, 2016, Biochemical and Biophysical Research Communications CrossRef
  35. Extracellular vesicles in ovarian cancer: applications to tumor biology, immunotherapy and biomarker discovery
    Muhammad Nawaz et al, 2016, Expert Review of Proteomics CrossRef
  36. null
    J.M. Street et al, 2017 CrossRef
  37. MicroRNA and Long Non-Coding RNA in Ovarian Carcinoma: Translational Insights and Potential Clinical Applications
    Yu Ma et al, 2016, Cancer Investigation CrossRef
  38. Emerging diagnostic, prognostic and therapeutic biomarkers for ovarian cancer
    Khalid El Bairi et al, 2017, Cell Oncol. CrossRef
  39. Wood kraft pulp supplementation alters the rumen fermentation characteristics and epithelial transcriptomes in Holstein cattle during the high-grain diet challenge
    Yo-Han Kim et al, 2019, Animal Feed Science and Technology CrossRef
  40. Ovarian Cancer: Differentially Expressed microRNAs in Tumor Tissue and Cell-Free Ascitic Fluid as Potential Novel Biomarkers
    Luděk Záveský et al, 2019, Cancer Investigation CrossRef
  41. null
    Ludek Zavesky et al, 2017 CrossRef
  42. miR-376c promotes carcinogenesis and serves as a plasma marker for gastric carcinoma
    Pei-Shih Hung et al, 2017, PLoS ONE CrossRef
  43. The emerging roles and therapeutic potential of exosomes in epithelial ovarian cancer
    Xiaoduan Li et al, 2017, Mol Cancer CrossRef
  44. null
    Anfal Jasim et al, 2017 CrossRef
  45. Updates and current challenges in microRNA research for personalized medicine in ovarian cancer
    Victoria Mandilaras et al, 2017, Expert Opinion on Biological Therapy CrossRef
  46. Liquid biopsy in Ovarian cancer using Circulating Tumor DNA and Cells: Ready for Prime Time?
    Du-Bois Asante et al, 2019, Cancer Letters CrossRef
  47. Plasma miR-30a-5p as an early novel noninvasive diagnostic and prognostic biomarker for lung cancer
    Ling-Bo Liang et al, 2019, Future Oncology CrossRef
  48. Circulating and Tissue microRNAs as Biomarkers for Ovarian Cancer Prognosis
    Seyed Mostafa Parizadeh et al, 2019, CDT CrossRef
  49. Isolation and Detection Technologies of Extracellular Vesicles and Application on Cancer Diagnostic
    Chunyan Ma et al, 2019, Dose-Response CrossRef
  50. Role of microRNAs as Clinical Cancer Biomarkers for Ovarian Cancer: A Short Overview.
    Cristina Elena Staicu et al, 2020, Cells CrossRef
  51. null
    Jaroslav Juracek et al, 2020 CrossRef
  52. Screening and Prevention for High-Grade Serous Carcinoma of the Ovary Based on Carcinogenesis—Fallopian Tube- and Ovarian-Derived Tumors and Incessant Retrograde Bleeding
    Isao Otsuka et al, 2020, Diagnostics CrossRef
  53. Urine as a biological modality for colorectal cancer detection
    Subashini Chandrapalan et al, 2020, Expert Review of Molecular Diagnostics CrossRef
  54. Update on urine as a biomarker in cancer: a necessary review of an old story
    Wei Zhang et al, 2020, Expert Review of Molecular Diagnostics CrossRef
  55. Exosomal non-coding RNAs: a promising cancer biomarker
    Huan Yang et al, 2016 CrossRef
  56. In situ one-step fluorescence labeling strategy of exosomes via bioorthogonal click chemistry for real-time exosome tracking in vitro and in vivo
    Sukyung Song et al, 2020, Bioconjugate Chem. CrossRef
  57. The diagnostic, prognostic and therapeutic potential of circulating microRNAs in ovarian cancer
    Hamideh Aboutalebi et al, 2020, The International Journal of Biochemistry & Cell Biology CrossRef
  58. Early diagnosis of breast and ovarian cancers by body fluids circulating tumor-derived exosomes
    Leyla Norouzi-Barough et al, 2020, Cancer Cell Int CrossRef
  59. Decreased MiR-30a promotes TGF-β1-mediated arachnoid fibrosis in post-hemorrhagic hydrocephalus
    Chaohong Zhan et al, 2020 CrossRef
  60. Publication Trends in Exosomes Nanoparticles for Cancer Detection

    Saba Ale Ebrahim et al, 2020, IJN CrossRef
  61. Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review)
    Alessia Finotti et al, 2018, Int J Oncol CrossRef
  62. A highly efficient method for isolating urinary exosomes
    Liuqing He et al, 2018, Int J Mol Med CrossRef
  63. FOXD1 is targeted by miR-30a-5p and miR-200a-5p and suppresses the proliferation of human ovarian carcinoma cells by promoting p21 expression in a p53-independent manner.
    Yu Wang et al, 0 CrossRef
  64. Quantification of circulating microRNAs by droplet digital PCR for cancer detection
    Priscila D. R. Cirillo et al, 2020, BMC Res Notes CrossRef
  65. The Role of microRNAs in Epithelial Ovarian Cancer Metastasis
    Vu Hong Loan Nguyen et al, 2020, IJMS CrossRef
  66. Bioinformatics analysis of prognostic value and prospective pathway signal of miR-30a in ovarian cancer
    Weijia Lu et al, 2020, J Ovarian Res CrossRef
  67. Mutually distinguishing microRNA signatures of breast, ovarian and endometrial cancers in�vitro
    Marc Hirschfeld et al, 2020, Mol Med Rep CrossRef
  68. Non-Invasive Early Molecular Detection of Gastric Cancers
    Hiroyuki Yamamoto et al, 2020, Cancers CrossRef
  69. Circulating Extracellular Vesicles in Gynecological Tumors: Realities and Challenges
    Carolina Herrero et al, 2020, Front. Oncol. CrossRef
  70. MicroRNA as Biomarker in Ovarian Cancer Management: Advantages and Challenges
    Vivek Kumar et al, 2020, DNA and Cell Biology CrossRef
  71. Candidate RNA biomarkers in biofluids for early diagnosis of ovarian cancer: A systematic review
    Eva Hulstaert et al, 2020, Gynecologic Oncology CrossRef
  72. Urindiagnostik – die neue Liquid Biopsy
    Elmar Stickeler, 2021, Gynäkologe CrossRef
  73. Cell-free microRNA-1246 in different body fluids as a diagnostic biomarker for esophageal squamous cell carcinoma.
    Isamu Hoshino et al, 2021, PLoS One CrossRef
  74. Emerging technologies and commercial products in Exosome-Based Cancer Diagnosis and Prognosis
    Mehdi Mohammadi et al, 2021, Biosensors and Bioelectronics CrossRef
  75. null
    Sai V. Chitti et al, 2021 CrossRef
  76. In Silico screening of circulating tumor DNA, circulating microRNAs, and long non-coding RNAs as diagnostic molecular biomarkers in ovarian cancer: A comprehensive meta-analysis
    Linlin Zhang et al, 2021, PLoS ONE CrossRef
  77. Plasma-derived exosomal miR-4732-5p is a promising noninvasive diagnostic biomarker for epithelial ovarian cancer.
    Jingjing Liu et al, 2021, J Ovarian Res CrossRef
  78. Current Implications of microRNAs in Genome Stability and Stress Responses of Ovarian Cancer
    Arkadiusz Gajek et al, 2021, Cancers CrossRef
  79. Graphene oxide-based qRT-PCR assay enables the sensitive and specific detection of miRNAs for the screening of ovarian cancer
    Chenyan Hu et al, 2021, Analytica Chimica Acta CrossRef
  80. MicroRNA-30a-5p promotes differentiation in neonatal mouse spermatogonial stem cells (SSCs)
    Maryam Khanehzad et al, 2021, Reprod Biol Endocrinol CrossRef
  81. Increased microRNA-30a levels in bronchoalveolar lavage fluid as a diagnostic biomarker for lung cancer.
    Wen-Jun Zhu et al, 2021, PeerJ CrossRef
  82. Nanobiodevices for the Isolation of Circulating Nucleic Acid for Biomedical Applications
    Hiromi Takahashi et al, 2021, Chem. Lett. CrossRef
  83. Engineered EV-Mimetic Nanoparticles as Therapeutic Delivery Vehicles for High-Grade Serous Ovarian Cancer
    Amal A. Al-Dossary et al, 2021, Cancers CrossRef
  84. Identification and Confirmation of the miR-30 Family as a Potential Central Player in Tobacco-Related Head and Neck Squamous Cell Carcinoma
    Tingting Zhang et al, 2021, Front. Oncol. CrossRef
  85. Identification of Key Circulating Exosomal microRNAs in Gastric Cancer
    Xiaoqing Qian et al, 2021, Front. Oncol. CrossRef
  86. Circulating microRNAs from the Molecular Mechanisms to Clinical Biomarkers: A Focus on the Clear Cell Renal Cell Carcinoma
    Claudia Tito et al, 2021, Genes CrossRef
  87. Targeting USP22 with miR‑30‑5p to inhibit the hypoxia‑induced expression of PD‑L1 in lung adenocarcinoma cells
    Xiaoyang Hua et al, 2021, Oncol Rep CrossRef
  88. null
    Marco Petrillo et al, 2021 CrossRef
  89. New Trends in the Detection of Gynecological Precancerous Lesions and Early-Stage Cancers
    Jitka Holcakova et al, 2021, Cancers CrossRef
  90. Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer
    Carolina Maria Sassu et al, 2021, IJMS CrossRef
  91. Nucleic acids and proteins carried by exosomes of different origins as potential biomarkers for gynecologic cancers
    Miaomiao Ye et al, 2022, Molecular Therapy - Oncolytics CrossRef
  92. null
    Diego Aviles et al, 2021 CrossRef
  93. MicroRNA-30a contributes to pre-eclampsia through regulating the proliferation, apoptosis, and angiogenesis modulation potential of mesenchymal stem cells by targeting AVEN
    Fangle Gu et al, 2022, Bioengineered CrossRef
  94. Urinary biomarkers for the detection of ovarian cancer: a systematic review
    Gemma L Owens et al, 2022 CrossRef
  95. Exosomal MicroRNA as Biomarkers for Diagnosing or Monitoring the Progression of Ovarian Clear Cell Carcinoma: A Pilot Study
    Kayo Horie et al, 2022, Molecules CrossRef
  96. Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case–control study
    Kai Berner et al, 2021, Arch Gynecol Obstet CrossRef
  97. The Exosome Journey: From Biogenesis to Regulation and Function in Cancers
    Yuan Li et al, 2022, Journal of Oncology CrossRef
  98. Plasma exosomal miR-1260a, miR-7977 and miR-192-5p as diagnostic biomarkers in epithelial ovarian cancer
    Liang Chen et al, 2022, Future Oncology CrossRef
  99. Extracellular vesicle contents as non-invasive biomarkers in ovarian malignancies
    Lindsey A. McAlarnen et al, 2022, Molecular Therapy - Oncolytics CrossRef
  100. null
    Tarang Sharma et al, 2022 CrossRef
  101. null
    Arnau Pallares-Rusiñol et al, 2022 CrossRef
  102. Status quo of Extracellular Vesicle isolation and detection methods for clinical utility
    Kekoolani S Visan et al, 2022, Seminars in Cancer Biology CrossRef
  103. Preoperative serum microRNAs as potential prognostic biomarkers in ovarian clear cell carcinoma
    Kazuhiro Suzuki et al, 2023, J Gynecol Oncol CrossRef
  104. Exosomes: A potential tool for immunotherapy of ovarian cancer
    Xiangjin Gong et al, 2023, Front. Immunol. CrossRef
  105. Circulating tumor DNA: a noninvasive biomarker for tracking ovarian cancer.
    Fang Yang et al, 2021, Reprod Biol Endocrinol CrossRef
  106. Circulating Biomarkers for Cancer Detection: Could Salivary microRNAs Be an Opportunity for Ovarian Cancer Diagnostics?
    Marzia Robotti et al, 2023, Biomedicines CrossRef
  107. Extracellular urinary microRNAs as non-invasive biomarkers of endometrial and ovarian cancer
    Antonija Hanžek et al, 2023, J Cancer Res Clin Oncol CrossRef
  108. Recent progress in exosome research: isolation, characterization and clinical applications
    Xi Wang et al, 2023, Cancer Gene Ther CrossRef
  109. Evaluation of the Potential Diagnostic Utility of the Determination of Selected Immunological and Molecular Parameters in Patients with Ovarian Cancer
    Aleksandra Englisz et al, 2023, Diagnostics CrossRef
  110. Emerging diversity in extracellular vesicles and their roles in cancer
    Ikjot S. Sohal et al, 2023, Front. Oncol. CrossRef
  111. Paper-based biosensors as point-of-care diagnostic devices for the detection of cancers: a review of innovative techniques and clinical applications
    Mehrdad Mahmoodpour et al, 2023, Front. Oncol. CrossRef
  112. Curcumin modulates cell type-specific miRNA networks to induce cytotoxicity in ovarian cancer cells
    Febina Ravindran et al, 2023, Life Sciences CrossRef
  113. Exosome-transmitted miR-30a-5p enhances cell proliferation, migration, and invasion in ovarian cancer
    Jian Cao et al, 2023, Cell Div CrossRef
  114. Recent Progress in Prompt Molecular Detection of Exosomes Using CRISPR/Cas and Microfluidic‐Assisted Approaches Toward Smart Cancer Diagnosis and Analysis
    Seyyed Mojtaba Mousavi et al, 2023, ChemMedChem CrossRef
  115. Clinical relevance of exosome-derived microRNAs in Ovarian Cancer: looking for new tumor biological fingerprints
    Daniele Fanale et al, 2023, Critical Reviews in Oncology/Hematology CrossRef
  116. Research Progress of Circulating Tumor DNA in the Diagnosis and Treatment of Gynecological Malignant Tumors
    ·木塔力甫 木尼热克孜, 2024, ACM CrossRef
  117. High-Grade Serous Ovarian Cancer—A Risk Factor Puzzle and Screening Fugitive
    Jacek Wilczyński et al, 2024, Biomedicines CrossRef
  118. Applications of Exosome Vesicles in Different Cancer Types as Biomarkers
    Murat Ihlamur et al, 2024, CMM CrossRef